Skip to main content

Table 1 Baseline population characteristics

From: Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection

Parameters

Chronic HBV infection

Total (n = 291)

HBeAg positive

HBeAg negative

P# value

Total (n = 156)

Immune tolerant, IT (n = 35)

HBeAg positive immune active hepatitis, EPIA (n = 121)

Total (n = 135)

Inactive chronic hepatitis B, ICH (n = 77)

HBeAg negative reactive hepatitis, ENH (n = 58)

Age, years

median(IQR)

37(30,46)

33(28,41)

30(27.5,34.0)

34.0 (28.0,42.0)

41(33,52)

40.0 (31.0,50.0)

42.0(35.0,53.0)

0.000

Gender, M/F

206/85

114/42

25/10

89/32

92/43

45/32

47/11

0.028

Disease category(CH/LC/HCC)

240/51/0

125/31/0

30/0/0

90/31/0

115/20/0

74/3/0

41/17/0

/

Child-Pugh class(A/B/C)

31/11/9

23/4/4

na

23/4/4

8/7/5

1/1/1

7/6/4

/

HBsAg, log IU/mL, median(IQR)

3.49(2.91,4.12)

3.92(3.27,4.56)

4.56(4.13,4.71)

3.71(3.22,4.31)

2.98(2.38,3.58)

2.94(2.32,3.54)

3.00(2.48,3.66)

0.000

HBeAg, log S/CO median(IQR)

na

2.81(1.67,3.11)

3.01(3.07,3.17)

2.58(1.46,3.03)

na

na

na

0.005

HBV DNA,log copies/mL, median(IQR)

5.94(3.63,8.14)

7.65(5.87,8.43)

8.44(8.15,8.43)

7.11(5.39,8.44)

3.61(2.74,5.20)

2.74(2.74,3.82)

5.48(4.09,6.65)

0.000

HBV RNA,log copies/mL

median(IQR)

5.50(2.57,7.16)

6.82(5.57,7.98)

7.87(6.08,8.30)

6.67(5.433,7.80)

2.40(2.00,5.23)

2.00(2.00,3.04)

5.31(3.57,6.37)

0.000

ALT,IU/L median(IQR)

59(30,191)

88.5(42.5261.0)

34(28.5,43.5)

153(66.50,348.50)

36(20,100.50)

24(18,34)

131(67,309)

0.000

AST,IU/L median(IQR)

41(23,102)

58.5(31,116)

27(23,31.5)

76.5(44,157)

27(21,56)

21(19,26)

89.5(39,188)

0.000

  1. IQR interquantile range, HBeAg Hepatitis B e antigen, CH chronic hepatitis, LC liver cirrhosis, na not applicable, HCC hepatocellular carcinoma, HBsAg Hepatitis B surface antigen, HBV hepatitis B virus, AST aspartate aminotransferase, ALT alanine aminotransferase. P# value: compared between patients with HBeAg-positive and patients with HBeAg-negative